Insider Trading activities of Biomarin Pharmaceutical Inc insiders. , Part 3

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $391,867,316.
The total value of stock option exercises since 2005 is $108,663,205.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN) , Part 3
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2014-02-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2014-02-03 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 67.70 676,970
2014-02-03 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 21.51 215,100
2014-01-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 70.00 350,000
2014-01-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-01-06 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 67.41 674,100
2014-01-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2014-01-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 68.90 344,485
2014-01-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2014-01-02 Fuchs Henry J (EVP, Chief Medical Officer) Sale 916 68.97 63,171
2013-12-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 68.71 687,140
2013-12-11 Grey Michael G Sale 30,000 69.66 2,089,680
2013-12-11 Grey Michael G Option Ex 30,000 21.78 653,310
2013-12-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 13,026 69.55 906,010
2013-12-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 13,026 17.92 233,425
2013-12-09 Lawlis V Bryan Sale 2,900 69.76 202,301
2013-12-09 Lewis Alan Sale 22,500 69.91 1,572,975
2013-12-09 Lewis Alan Option Ex 22,500 32.54 732,150
2013-12-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 69.70 348,485
2013-12-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 9,000 70.14 631,269
2013-12-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 9,000 39.06 351,540
2013-11-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-11-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 62.36 311,780
2013-11-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-11-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 99 63.16 6,252
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 62.72 627,160
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 67.72 135,450
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-10-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 66.76 200,292
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 80.19 801,900
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 73.08 146,164
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-09-09 Baffi Robert (EVP, Technical Operations) Sale 20,000 73.00 1,460,000
2013-09-09 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 70.00 700,000
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 9,000 69.00 621,000
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 9,000 39.06 351,540
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 64.36 64,364
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 12.99 12,990
2013-07-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 38.34 76,688
2013-07-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,066 59.78 243,061
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 60.00 600,000
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-06-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-06-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 43.89 877,800
2013-06-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 36.85 737,099
2013-06-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 493 58.34 28,763
2013-06-03 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,098 58.32 64,036
2013-05-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-05-23 Fuchs Henry J (EVP, Chief Medical Officer) Sale 8,710 67.16 584,981
2013-05-22 Wood Mark (VP, Human Resources) Sale 3,103 67.12 208,282
2013-05-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Sale 11,899 65.66 781,240
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.14 128,277
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-05-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 64.01 320,050
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.65 129,306
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 38.82 271,754
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 68.55 685,480
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-05-14 Mueller Brian (VP, Corporate Controller) Sale 4,947 70.37 348,130
2013-05-14 Mueller Brian (VP, Corporate Controller) Option Ex 3,500 21.51 75,285
2013-05-14 Davis George Eric (SVP, General Counsel) Sale 20,000 70.34 1,406,800
2013-05-14 Davis George Eric (SVP, General Counsel) Option Ex 20,000 21.51 430,200
2013-05-14 Baffi Robert (EVP, Technical Operations) Sale 20,000 70.00 1,400,000
2013-05-14 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 40,000 70.56 2,826,590
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 40,000 12.99 519,600
2013-05-13 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,248 69.25 86,430
2013-05-13 Davis George Eric (SVP, General Counsel) Sale 2,590 69.29 179,453
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 68.98 1,034,640
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2013-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 800 67.48 53,984
2013-05-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 811 66.00 53,528
2013-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 65.88 65,879
2013-05-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 65.87 197,612
2013-05-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-05-03 Mueller Brian (VP, Corporate Controller) Sale 7,500 67.11 503,294
2013-05-03 Mueller Brian (VP, Corporate Controller) Option Ex 7,500 21.51 161,325
2013-05-03 Davis George Eric (SVP, General Counsel) Sale 5,854 67.19 393,324
2013-05-03 Davis George Eric (SVP, General Counsel) Option Ex 5,854 15.96 93,459
2013-05-03 Baffi Robert (EVP, Technical Operations) Sale 20,000 67.00 1,340,000
2013-05-03 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-05-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 67.24 537,896
2013-05-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2013-05-02 Mueller Brian (VP, Corporate Controller) Sale 9,331 65.42 610,387
2013-05-02 Mueller Brian (VP, Corporate Controller) Option Ex 4,874 14.39 70,136
2013-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 65.62 131,240
2013-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-05-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 797 64.52 51,420
2013-05-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 28,000 64.42 1,803,900
2013-05-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 28,000 39.06 1,093,680
2013-04-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 63.74 63,742
2013-04-30 Fuchs Henry J (EVP, Chief Medical Officer) Sale 20,000 63.29 1,265,800
2013-04-30 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 20,000 11.05 221,000
2013-04-22 Wood Mark (VP, Human Resources) Sale 3,102 65.58 203,413
2013-04-22 Wood Mark (VP, Human Resources) Option Ex 3,102 24.96 77,432
2013-04-19 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 5,000 65.00 325,000
2013-04-19 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 5,000 21.51 107,550
2013-04-10 Baffi Robert (EVP, Technical Operations) Sale 20,000 64.00 1,280,000
2013-04-10 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-03-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 12,000 60.68 728,148
2013-03-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 12,000 12.99 155,880
2013-03-22 Wood Mark (VP, Human Resources) Sale 3,103 60.21 186,822
2013-03-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-03-18 Baffi Robert (EVP, Technical Operations) Sale 20,000 61.02 1,220,360
2013-03-18 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-03-06 Grey Michael G Sale 15,000 60.61 909,135
2013-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 4,000 60.00 240,000
2013-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 4,000 21.51 86,040
2013-03-04 Davis George Eric (SVP, General Counsel) Sale 4,000 60.18 240,724
2013-03-04 Davis George Eric (SVP, General Counsel) Option Ex 4,000 17.86 71,440
2013-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 60.00 300,000
2013-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-03-03 Grey Michael G Option Ex 15,000 14.39 215,850
2013-03-01 Mueller Brian (VP, Corporate Controller) Sale 7,038 59.77 420,682
2013-03-01 Mueller Brian (VP, Corporate Controller) Option Ex 5,023 23.61 118,608
2013-03-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 59.14 59,140
2013-02-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 58.00 290,000
2013-02-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-02-27 Davis George Eric (SVP, General Counsel) Sale 8,000 56.90 455,184
2013-02-27 Davis George Eric (SVP, General Counsel) Option Ex 8,000 15.96 127,720
2013-02-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 56.46 84,684
2013-02-27 Lewis Alan Sale 22,500 56.57 1,272,757
2013-02-27 Lewis Alan Option Ex 22,500 24.83 558,675
2013-02-26 Lapalme Pierre Sale 29,900 55.34 1,654,785
2013-02-26 Lapalme Pierre Option Ex 29,900 9.81 293,319
2013-02-22 Wood Mark (VP, Human Resources) Sale 3,103 55.13 171,071
2013-02-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-02-19 Meier Richard A Sale 5,000 57.50 287,500
2013-02-19 Meier Richard A Option Ex 5,000 16.92 84,600
2013-02-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 55.77 111,532
2013-02-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-01-23 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 55.22 220,880
2013-01-22 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 3,000 55.00 165,000
2013-01-22 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 3,000 21.51 64,530
2013-01-22 Wood Mark (VP, Human Resources) Sale 46,749 54.91 2,566,753
2013-01-22 Wood Mark (VP, Human Resources) Option Ex 46,749 27.69 1,294,386
2013-01-22 Baffi Robert (EVP, Technical Operations) Sale 19,575 55.00 1,076,625
2013-01-22 Baffi Robert (EVP, Technical Operations) Option Ex 19,575 17.54 343,345
2013-01-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 55.00 550,000
2013-01-18 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 54.00 270,000
2013-01-18 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-01-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 52.24 156,732
2013-01-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-01-03 Baffi Robert (EVP, Technical Operations) Sale 20,000 53.00 1,060,000

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.